Westmead Hospital is a major tertiary hospital in Sydney, Australia. Opened on 10 November 1978, the 975-bed hospital forms part of the Western Sydney Local Health District, and is a teaching hospital of Sydney Medical School at the University of Sydney.

There are 958 beds in Westmead Hospital.

During the past decade, Westmead Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Westmead Hospital" #1 sponsor was "Trans Tasman Radiation Oncology Group" with 12 trials, followed by "Bayer" with 2 trials sponsored, "Loxo Oncology, Inc." with 2 trials sponsored, "BioCryst Pharmaceuticals" with 1 trials sponsored and "BioMarin Pharmaceutical" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Westmead Hospital" #1 collaborator was "Australasian Leukaemia and Lymphoma Group" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "National Health and Medical Research Council, Australia" with 2 trials as a collaborator, "Peter MacCallum Cancer Centre, Australia" with 2 trials as a collaborator and "3M" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Westmead Hospital" are "Chronic Lymphocytic Leukemia" (2 trials), "Influenza" (2 trials), "Small Lymphocytic Lymphoma" (2 trials), "Adenocarcinoma of Rectum" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Westmead Hospital" in a lesser frequency.

Most popular intervention types in "Westmead Hospital" are "Drug" (19 trials), "Radiation" (11 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Radiotherapy" (5 trials), "Rituximab" (3 trials), "Bendamustine" (2 trials), "Placebo" (2 trials) and "40 mg Laninamivir Octanoate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Westmead Hospital" are 21 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Westmead Hospital". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Westmead Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Westmead Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".